MPR News is tracking federal immigration actions across Minnesota — from U.S. Immigration and Customs Enforcement operations and policy changes to community impact and your rights. What to do if ICE ...
Companies are starting to get refunds for tariffs that have been struck down by the Supreme Court. But many businesses that helped bear the costs of those tariffs aren’t eligible. Candace Stock had ...
The approval was supported by data from the OPERETTA 2 trial, which evaluated ocrelizumab in pediatric patients aged 10 years to less than 18 years of age with RRMS.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results